Damian Garde

Today’s biotech news includes the evolving definition of “insider trading,” Pfizer’s RSV vaccine, and the rise of the biotech index XBI.

Today’s biotech news includes the Supreme Court’s moves on mifepristone, going public in 2024, and a contrarian view on Viking Therapeutics.

STAT’s Sarah Owermohle joins us to explain the SCOTUS case that could have dramatic effects on access to the abortion pill mifepristone.

Today’s biotech news includes a potentially major drug approval, an idea to make CAR-T more equitable, and the slow launch of a gene therapy.

Today’s biotech news roundup includes Viking’s obesity drug results, AbbVie’s curious purchase, and Merck’s expected FDA approval.

We discuss summit highlights, including words from CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos.

Today’s biotech updates include Argenx share updates, BioNTech’s Pfizer moment, Intra-Cellular Therapies studies on major depressive disorder

At STAT Breakthrough Summit, Regeneron’s George Yancopoulos discusses new allergy treatments, better weight loss drugs, and his high school science project.

Today’s biotech news updates include Novo Nordisk AI, AstraZeneca x Fusion, and a bright (and lucrative) idea in cancer research.

Today’s biotech news includes a pioneering new gene therapy for MLD, the plight of WuXi AppTec in the U.S., and more.